Browsing by Author "Rašić, Dejan (24400176900)"
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Acute post-surgical bilateral orbital gas-producing infection - A case report and literature review(2012) ;Knežević, Miroslav (36192212000) ;Rašić, Dejan (24400176900) ;Stojković, Milenko (57197223369) ;Jovanović, Miloš (57212520802)Božić, Marija (26640219200)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Acute post-surgical bilateral orbital gas-producing infection - A case report and literature review(2012) ;Knežević, Miroslav (36192212000) ;Rašić, Dejan (24400176900) ;Stojković, Milenko (57197223369) ;Jovanović, Miloš (57212520802)Božić, Marija (26640219200)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Buffered Versus Nonbuffered Local Anesthetics and Local Pain Scores in Upper Eyelid Blepharoplasty: Randomized Controlled Trial(2023) ;Vasović, Dolika D. (57194764843) ;Karamarković, Miodrag (58221575100) ;Stojičić, Milan (24554259500) ;Jovanović, Milan (57210477379) ;Savić Vujović, Katarina (57217857650) ;Rašić, Dejan (24400176900) ;Colić, Milan (57196813142)Musić, Nikola (57221293955)Purpose: This split-face study aimed to see whether different types of local anesthetics or their buffered/nonbuffered combinations produce lower pain scores in upper eyelid blepharoplasty. Methods: The study involved 288 patients, randomly divided into 9 groups: 1) 2% lidocaine with epinephrine - Lid + Epi; 2) 2% lidocaine with epinephrine and 0.5% bupivacaine (1:1) - Lid + Epi + Bupi; 3) 2% lidocaine with 0.5% bupivacaine (1:1) - Lid + Bupi; 4) 0.5% bupivacaine - Bupi; 5) 2% lidocaine - Lid; 6) 4% articaine hydrochloride with epinephrine - Art + Epi; 7) buffered 2% lidocaine/epinephrine with sodium bicarbonate (SB) in a 3:1 ratio - Lid + Epi + SB; 8) buffered 2% lidocaine with SB in a 3:1 ratio - Lid + SB; 9) buffered 4% articaine hydrochloride/epinephrine with SB in a 3:1 ratio - Art + Epi + SB. Following the injection of the first eyelid and a 5-minute period of soft pressure on the injection site, patients were asked to rate their pain level on the Wong-Baker Face Pain Rating Visual Analogue Scale. Rating of the pain level was repeated 15 and 30 minutes following anesthetic administration. Results: The lowest pain scores at the first time point were observed in Lid + SB when compared with all of the other groups (p < 0.05). At the final time point, significantly lower scores were also observed in Lid + SB, Lid + Epi + SB, and Art + Epi + SB when compared with the Lid + Epi group (p < 0.05). Conclusion: These findings could help surgeons select an appropriate combination of local anesthetics, particularly in patients with lower pain threshold and tolerance because buffered combinations of local anesthetics produce significantly lower pain scores compared with nonbuffered solutions. © 2023 Lippincott Williams and Wilkins. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Oncogene-induced senescence in meningiomas—an immunohistochemical study(2024) ;Mijajlović, Vladimir (58771884500) ;Miler, Marko (55926151300) ;Ilić, Rosanda (56688276500) ;Rašić, Dejan (24400176900) ;Dunđerović, Duško (56515503700) ;Raičević, Savo (56176851100) ;Soldatović, Ivan (35389846900) ;De Luka, Silvio (56957018200)Manojlović-Gačić, Emilija (36439877900)Purpose: Meningiomas are tumours originating from meningothelial cells, the majority belonging to grade 1 according to the World Health Organization classification of the tumours of the Central Nervous System. Factors contributing to the progression to the higher grades (grades 2 and 3) have not been elucidated yet. Senescence has been proposed as a potential mechanism constraining the malignant transformation of tumours. Senescence-associated beta-galactosidase (SA-β-GAL) and inhibitors of cyclin-dependent kinases p16 and p21 have been suggested as senescence markers. Methods: We analysed 318 meningiomas of total 343 (178 grade 1, 133 grade 2 and 7 grade 3). Tissue microarrays were constructed and stained immunohistochemically, using antibodies for SA-β-GAL, p16 and p21. Results: The positive correlation of the tumour grade with the expression of p16 (p = 0.016) and SA-β-GAL (p = 0.002) was observed. The expression of p16 and SA-β-GAL was significantly higher in meningiomas grade 2 compared to meningiomas grade 1 (p = 0.006 and p = 0.004, respectively). SA-β-GAL positivity positively correlated with p16 and p21 in the whole cohort. In grade 2 meningiomas, a positive correlation was only between SA-β-GAL and p16. Correlations of senescence markers in meningiomas grade 2 were not present. Conclusion: Our findings suggest the senescence activation in meningiomas grade 2 as a potential mechanism for the restraining of tumour growth and give hope for applying of promising senolytic therapy. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. - Some of the metrics are blocked by yourconsent settings
Publication Oncogene-induced senescence in meningiomas—an immunohistochemical study(2024) ;Mijajlović, Vladimir (58771884500) ;Miler, Marko (55926151300) ;Ilić, Rosanda (56688276500) ;Rašić, Dejan (24400176900) ;Dunđerović, Duško (56515503700) ;Raičević, Savo (56176851100) ;Soldatović, Ivan (35389846900) ;De Luka, Silvio (56957018200)Manojlović-Gačić, Emilija (36439877900)Purpose: Meningiomas are tumours originating from meningothelial cells, the majority belonging to grade 1 according to the World Health Organization classification of the tumours of the Central Nervous System. Factors contributing to the progression to the higher grades (grades 2 and 3) have not been elucidated yet. Senescence has been proposed as a potential mechanism constraining the malignant transformation of tumours. Senescence-associated beta-galactosidase (SA-β-GAL) and inhibitors of cyclin-dependent kinases p16 and p21 have been suggested as senescence markers. Methods: We analysed 318 meningiomas of total 343 (178 grade 1, 133 grade 2 and 7 grade 3). Tissue microarrays were constructed and stained immunohistochemically, using antibodies for SA-β-GAL, p16 and p21. Results: The positive correlation of the tumour grade with the expression of p16 (p = 0.016) and SA-β-GAL (p = 0.002) was observed. The expression of p16 and SA-β-GAL was significantly higher in meningiomas grade 2 compared to meningiomas grade 1 (p = 0.006 and p = 0.004, respectively). SA-β-GAL positivity positively correlated with p16 and p21 in the whole cohort. In grade 2 meningiomas, a positive correlation was only between SA-β-GAL and p16. Correlations of senescence markers in meningiomas grade 2 were not present. Conclusion: Our findings suggest the senescence activation in meningiomas grade 2 as a potential mechanism for the restraining of tumour growth and give hope for applying of promising senolytic therapy. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. - Some of the metrics are blocked by yourconsent settings
Publication Plurihormonal Pituitary Neuroendocrine Tumours – A Single Centre Experience(2024) ;Mihajlović, Milena (57223894750) ;Pekić, Sandra (6602553641) ;Doknić, Mirjana (6603478362) ;Stojanović, Marko (58191563300) ;Rašić, Dejan (24400176900) ;Miljić, Dragana (6505968542) ;Petakov, Milan (7003976693)Manojlović Gačić, Emilija (36439877900)Introduction. Plurihormonal pituitary neuroendocrine tumours (PitNET)/adenomas are pituitary neuroendocrine tumours composed of monomorphous cell populations expressing anterior pituitary transcription factors and/or hormones belonging to more than one cell lineage. Studies dedicated to plurihormonal tumours are rare and quite heterogenous with their results, bearing in mind changes in diagnostic criteria and inconsistent use of antibodies for anterior pituitary transcription factors in the diagnostic immunohistochemical panel. Material and Methods. We retrospectively analysed all patients surgically treated for PitNETs from 2016 to July 2022 in a tertiary healthcare institution. All tumours previously diagnosed PitNETs with the word “plurihormonal” were re-examined and potentially re-classified, according to 2022 WHO classification of endocrine tumours. Results. Among 721 patients surgically treated for PitNET in 5.5 years period, the diagnosis of plurihormonal PitNET was established in 11 tumours (1.3%). All tumours showed diffuse and intensive positivity for anterior pituitary transcription factors PIT1 and SF1. Clinically, all patients presented with acromegaly. Conclusions. Retrospective studies related to newly defined plurihormonal PitNETs with a reassessment of diagnoses are necessary due to their rarity and ambition to investigate their origin and biological behaviour. The fact that the majority of plurihormonal PitNETs are clinically presented with acromegaly and show simultaneous positivity to PIT1 and SF1 transcription factors deserve special attention and need for further research in larger cohorts of these exceptional tumours. © The Author(s) 2023. - Some of the metrics are blocked by yourconsent settings
Publication Recurrence of a small primary iris stromal cyst following treatment with Nd:YAG laser photodisruption in an adult(2017) ;Stanojlović, Svetlana (23502220700) ;Pajić, Sanja Petrović (57211992098) ;Krnjaja, Bojana Dačić (57196955455) ;Rašić, Dejan (24400176900)Jovanović, Miloš (57212520802)Introduction Primary acquired iris stromal cyst is rare in adults. In this group, they are generally stable lesions which require no treatment. Case outline We describe a rare case of a small primary iris cyst in a 39-year-old patient, associated with unusual signs of irritation. Ultrasound biomicroscopy demonstrated iris stromal cyst measuring 3 × 2 mm. A neodymium-doped yttrium aluminium garnet (Nd:YAG) laser cystotomy was engaged as the least invasive treatment approach. However, the cyst recurred soon after repeated laser treatment and sector iridectomy with excision of the cyst was performed. Five years after surgery there was no evidence of recurrence. Conclusion Although more benign clinical course of primary stromal iris cyst is generally assumed in adults as compared to children, complete cyst removal seems to be mandatory for preventing cyst recurrence regardless of the cyst size or patient age. To the authors’ knowledge this is the first documented report of Nd:YAG laser photodisruption of acquired primary iris stromal cyst in an adult. © 2017, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication The frequency of secondary glaucoma in patients with iridocorneal endothelial syndrome in correlation with the presence of uveal ectropion(2017) ;Marković, Vujica (56233157100) ;Radosavljević, Aleksandra (56993158000) ;Vuković, Dragan (57206290097) ;Jakšić, Vesna (23667666000) ;Božić, Marija (26640219200) ;Marjanović, Ivan (12775488400) ;Rašić, Dejan (24400176900)Marić, Vesna (57192098432)Introduction/Objective Iridocorneal endothelial (ICE) syndrome incudes 3 clinical forms: progressive iris atrophy, Chandler’s syndrome, and Cogan–Reese syndrome. It is characterized by various degrees of iris atrophy, corneal endothelial changes, uveal ectropion, corectopia, peripheral anterior synechiae (PAS) and secondary glaucoma. The aim of the study was to illustrate forms of ICE syndrome, determine frequency of secondary glaucoma with emphasis on cases with uveal ectropion, analyze response to medicament treatment and the need for surgical treatment in intraocular pressure (IOP) control. Methods Patients underwent slit lamp examination, applanation tonometry, gonioscopy, ophthalmoscopy, Humphrey visual field testing and Heidelberg retina tomography. Patients were divided into two groups: group I, without uveal ectropion (22 patients) and group II, with uveal ectropion (14 patients). Results A total of 36 patients were examined in a 10-year period. The average age was 38 years, male to female ratio 1:2. Secondary glaucoma was confirmed in 26 (72.2%) patients, out of which 12 (54.5%) in group I and 14 (100%) in group II. PAS were more frequent in group II. In group I, mean initial IOP was 37 mmHg, and after medicament treatment 26 mmHg. Secondary glaucoma was controlled in 50% and remaining 50% underwent surgical treatment. In group II, mean initial IOP was 49 mmHg, and after medicament treatment 32 mmHg. All 14 patients (100%) underwent surgical treatment in order to achieve IOP control. Conclusion ICE syndrome is a rare, progressive disease, with high incidence of secondary glaucoma, which is more frequent in cases with uveal ectropion. In these cases, medicament treatment is not effective and trabeculectomy with antimetabolite application is necessary. © 2017, Serbia Medical Society. All rights reserved.